Bain Capital Life Sciences Investors, LLC Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$1.6T
Holdings
33
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (33 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SWTXSPRINGWORKS THERAPEUTICS INC | 4,831,307 | $306.5B | 19.01% | |
| 2 | DVAXDYNAVAX TECHNOLOGIES CORP | 8,415,000 | $161.7B | 10.03% | |
| 3 | RPIDRAPID MICRO BIOSYSTEMS INC | 8,434,560 | $155.8B | 9.66% | |
| 4 | AVIRATEA PHARMACEUTICALS INC | 3,700,000 | $129.7B | 8.05% | |
| 5 | IVVDADAGIO THERAPEUTICS INC | 2,487,207 | $105.1B | 6.52% | |
| 6 | ARQTARCUTIS BIOTHERAPEUTICS INC. | 3,979,292 | $95.1B | 5.90% | |
| 7 | NUVLNUVALENT INC | 3,428,014 | $77.3B | 4.80% | |
| 8 | CCCCC4 THERAPEUTICS INC | 1,642,209 | $73.4B | 4.55% | |
| 9 | —DICERNA PHARMACEUTICALS INC | 3,080,237 | $62.1B | 3.85% | |
| 10 | ANNXANNEXON INC | 3,241,628 | $60.3B | 3.74% | |
| 11 | PHVSPHARVARIS N V | 3,180,601 | $56.4B | 3.50% | |
| 12 | NRIXNURIX THERAPEUTICS INC | 1,284,314 | $38.5B | 2.39% | |
| 13 | CRNXCRINETICS PHARMACEUTICALS | 1,679,701 | $35.4B | 2.19% | |
| 14 | —MERSANA THERAPEUTICS INC. | 3,695,667 | $34.9B | 2.16% | |
| 15 | —SYROS PHARMACEUTICALS INC | 5,785,036 | $25.9B | 1.60% | |
| 16 | TNGXTANGO THERAPEUTICS INC | 1,921,790 | $24.8B | 1.54% | |
| 17 | AGLEUSDAEGLEA BIO THERAPEUTICS INC | 2,847,689 | $22.6B | 1.40% | |
| 18 | —APTINYX INC | 8,891,758 | $20.8B | 1.29% | |
| 19 | SLDBSOLID BIOSCIENCES INC | 7,929,918 | $19.0B | 1.18% | |
| 20 | MRNS*MARINUS PHARMACEUTICALS INC | 1,431,058 | $16.3B | 1.01% | |
| 21 | YB4PSAVARA INC | 11,622,598 | $16.0B | 0.99% | |
| 22 | NAUTNAUTILUS BIOTECHNOLOGY INC | 2,000,000 | $12.3B | 0.76% | |
| 23 | ASNSUSDX4 PHARMACEUTICALS INC | 2,119,540 | $11.2B | 0.70% | |
| 24 | —RESEARCH ALLIANCE CORP II | 1,000,000 | $9.8B | 0.61% | |
| 25 | —BLUEBIRD BIO INC | 538,179 | $7.2B | 0.45% | |
| 26 | —ARYA SCIENCES ACQU CORP IV | 700,000 | $7.0B | 0.44% | |
| 27 | —ARYA SCIENCES ACQUISITN CORP | 500,000 | $4.9B | 0.31% | |
| 28 | —PANACEA ACQUISITION CORP II | 500,000 | $4.9B | 0.30% | |
| 29 | —BCLS ACQUISITION CORP | 487,500 | $4.9B | 0.30% | |
| 30 | —OMEGA ALPHA SPAC | 400,000 | $3.9B | 0.24% | |
| 31 | —FRAZIER LIFESCIENCES ACQU CO | 300,000 | $3.0B | 0.19% | |
| 32 | —JIYA ACQUISITION CORP | 300,000 | $2.9B | 0.18% | |
| 33 | MLTXHELIX ACQUISITION CORP | 250,000 | $2.5B | 0.15% |